Dr. Joan Fallon was working in private practice when she discovered that children with autism often had enzyme deficiencies. With the help of angel investors, she formed biotechnology firm Curemark in Rye, N.Y., and began working on an enzyme-replacement therapy. Her autism treatment, currently in trials, has been placed in the Food & Drug Administration's fast-track program, which expedites the review of new drugs. There is currently no drug that treats the core symptoms of autism, which affects one in 88 children, according to the Centers for Disease Control & Prevention.
In this video, we head to Yankee Stadium, where Fallon is a season-ticket holder. The ups and downs of baseball are a lot like entrepreneurship, she says. And the game is all about hope, something she hopes to bring to families dealing with autism.